Medicare

/Tag:Medicare

Client Alert: DIR Report Demonstrates Downside of Drug Rebates for Consumers and Medicare Program

January 26, 2017 — Earlier this month, the U.S. Centers for Medicare & Medicaid Services (CMS) issued an analysis of direct and indirect remuneration (DIR) fees. The data presented in the report makes clear that despite the claims of pharmacy benefit managers (PBMs) to the contrary, DIR fees do not reduce the costs of drugs for [...]

Client Alert: OIG Kicks off the New Year with Another Round of HHS Rule Changes

OIG Kicks off the New Year with Another Round of HHS Rule Changes Office of Inspector General Implements Important Changes to Exclusion Rules Continuing an onslaught of end-of-administration rule changes, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services (HHS) today published a 100-plus page final rule implementing a [...]